Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs)
@biogerontology
·
73d
The statement engages with a public issue related to drug development and regulatory practices, specifically the ethical considerations of CEOs using their own products. It encourages open-mindedness and personal endorsement of innovative ideas.
- The statement does not cause harm and encourages personal responsibility, aligning with the principle. [+1]Principle 1:I will strive to do no harm with my words and actions.
- It promotes understanding and empathy by supporting the idea of personal endorsement and reducing stigma. [+1]Principle 3:I will use my words and actions to promote understanding, empathy, and compassion.
- The statement invites constructive dialogue by asking for opinions and does not engage in personal attacks. [+1]Principle 4:I will engage in constructive criticism and dialogue with those in disagreement and will not engage in personal attacks or ad hominem arguments.
- It upholds free speech by encouraging open discussion on a potentially controversial topic. [+1]Principle 7:I will uphold the principles of free speech and use my platform responsibly and with integrity.